Target intelligence / Profile preview

Novel transcript, antisense to VPS53

Molecular classification: Other, putative non-coding RNA, antisense RNA

Overview

The target "novel transcript, antisense to VPS53" (ENSG00000262905) represents a non-coding RNA transcribed antisense to the VPS53 gene. It is not a classical therapeutic target such as a receptor, enzyme, or transporter. This entry describes an uncharacterized non-coding RNA of unknown function, with no described disease association, interacting drugs, mechanism of action, or biomarkers. Therefore, it is considered an incorrect or non-established molecular target.

Other names: ENSG00000262905antisense to VPS53

Beyond the preview

Go deeper on Novel transcript, antisense to VPS53.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to VPS53.

Explore the full profile